449-30295-77158
2 vaccinations
3 coded responses
10 check-ins
3 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 606 / IL
- Registered
- 2021-02-10
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Dose 1 — Moderna
-
2021-02-10
Registered in v-safe
-
2021-02-10
Dose 2 — Moderna
-
2021-02-10
Health check-in — day 0, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-02-10
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-11
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-02-12
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessFree text: Mild shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
-
2021-03-05
Survey response — day 21, dose 2MedDRA: Pregnancy, Premature rupture of membranes — Feeling: Fair · Be unable to workFree text: Developed premature rupture of membranes at 29 weeksMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-05
-
2021-03-11
Survey response — day 28, dose 2MedDRA: Pregnancy, Premature rupture of membranes — Feeling: Good · Be unable to workFree text: Admitted to hospital at 29 weeks with premature rupture of membranesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
- 2021-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Moderna | |
| 2 | 2021-02-10 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-10 | priority 2/3 | |
| 2021-02-11 | priority 2/3 | |
| 2021-03-05 | priority 2/3 | |
| 2021-03-11 | priority 2/3 |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Mild shortness of breath
Release 5 — day 21, dose 2
Symptoms: Developed premature rupture of membranes at 29 weeks
Release 5 — day 28, dose 2
Symptoms: Admitted to hospital at 29 weeks with premature rupture of membranes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SD | Premature rupture of membranes | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release